Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Wockhardt, Ltd.
483
•Wockhardt, Ltd.•December 15, 2015

Wockhardt, Ltd. – FDA 483, Dec 15, 2015

Record Details

The FDA inspection of a pharmaceutical manufacturing facility revealed multiple quality system and manufacturing deficiencies.

**Quality Unit Oversight and Documentation:** * Lack of Quality Unit oversight/approvals for document destruction, with shredded raw material labels, maintenance work orders, and hot work permits found awaiting incineration. * An uncontrolled personal diary containing experimental protocol and laboratory data, including calculations and molecular weights, was found in the Process Development Laboratory, which handles quality failure investigations and process testing. * Record entries were not always made contemporaneously or permanently, and corrections did not always preserve the original entry.

**Laboratory Control Issues:** * Aseptic media fill sterility testing for the Aseptic processing area used finished sterile API containers, but remaining containers were sampled but not tested for sterility, only retained for failure investigation. * Worst-case locations for microbial environmental swabs and contact plates in the sterile production area were not identified. * Three out of ten sterile gowns had unraveled stitching threads (1-3 cm) and one had shredded boot strap ties (>10 cm) in the sterile manufacturing block. * Lack of traceability for environmental isolates recovered from the production area, and microbial cultures were stored together in the same bag. * Operator interventions, including hand movements, interfered with unidirectional airflow during aseptic connections in a Laminar Air Flow unit, as observed in a smoke study simulation report.

**Computerized System Deficiencies:** * Prior to July

Company
Wockhardt, Ltd.
Inspection date
December 15, 2015
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Daniel J. Roberts ( Assistant Country Director (USFDA India Office Drug Program))
View Company Profile

ID · 6a3762ec-6bc4-4575-8d18-c27016b49959

Other documents for Wockhardt, Ltd.
  • WARNING_LETTER - 2015-12-15December 15, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wockhardt, Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.